“Anti-Choke Mug” – Chula Innovation for Neuro Patients to Drink Water Confidently

Chula Medicine has designed an anti-choke mug with calculated angle, amount, and time of water flow from the mug to the patient’s lips hoping to reduce choking that may lead to lung infection, bring peace of mind to caregivers, and make it safer for patients who will have a better quality of life.

ENRICH Trial Findings Debuts at the 2023 American Association of Neurological Surgeons Annual Scientific Meeting

The latest science and trial results were unveiled during the 2023 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in Los Angeles. The late-breaking abstract “Efficacy and Safety of Early Minimally Invasive Removal of Intracerebral Hemorrhage (ENRICH): a Multicenter Randomized Adaptive Trial,” was showcased Saturday, April 22.

Most COVID-19 long-haulers continue to experience neurologic symptoms, fatigue, and compromised quality of life 15 months after initial infection

A new study published in Annals of Clinical and Translational Neurology looked at the evolution of neurologic symptoms in non-hospitalized COVID-19 long-haulers at the Northwestern Medicine Neuro COVID-19 Clinic and discovered most long-haulers continue to experience symptoms such as brain fog, numbness/tingling, headache, dizziness, blurred vision, tinnitus and fatigue on average of 15 months after disease onset.

American Association of Neurological Surgeons Honors 2022 Award Winners

The American Association of Neurological Surgeons presented several major awards during the 2022 AANS Annual Scientific Meeting in Philadelphia. These awards honor the lifetime contribution of members for their surgical, scientific and humanitarian accomplishments.

New study finds persistent viral shedding of COVID-19 is associated with delirium and six-month mortality in hospitalized COVID-19 patients

The Northwestern Medicine Neuro COVID-19 research team discovered patients who continued to test positive more than 14 days after their initial positive test were more likely to experience delirium, longer hospital stays, were less likely to be discharged home, and had a greater six-month mortality than those without persistent viral shedding of COVID-19.

Key to resilient energy-efficient AI/machine learning may reside in human brain

A clearer understanding of how a type of brain cell known as astrocytes function and can be emulated in the physics of hardware devices, may result in artificial intelligence (AI) and machine learning that autonomously self-repairs and consumes much less energy than the technologies currently do, according to a team of Penn State researchers.

People With Stroke Who Walk 30 Minutes Per Day May Have 54% Lower Risk of Death

MINNEAPOLIS – A new study shows that people who walk or garden at least three to four hours per week, or bike at least two to three hours per week, or the equivalent after having a stroke may have a 54% lower risk of death from any cause. The research is published in the August 11, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study found the most benefit for younger stroke survivors. When people under the age of 75 exercised at least that amount, their risk of death was reduced by 80%.

Henry Ford Health System First in the U.S. to Offer Next Generation Deep Brain Stimulation System For Parkinson’s Disease

The Parkinson’s Disease and Movement Disorder Center at Henry Ford Health System was the first in the United States to offer a new FDA-approved device to help treat the symptoms of Parkinson’s disease. Neurosurgeon Jason Schwalb, M.D. surgically implanted the Vercise Genus™ Deep Brain Stimulation (DBS) System, which stimulates a targeted region of the brain through implanted leads that are placed in the brain.

University of Minnesota, Van Andel Institute earn $6M to study aging’s role in Parkinson’s

GRAND RAPIDS, Mich. (Sept. 21, 2020) — A collaborative team between the University of Minnesota Medical School and Van Andel Institute (VAI) will soon begin a $6.2 million study that seeks to define the molecular linkages between aging and Parkinson’s disease — an approach for new treatment targets not yet explored by many researchers. The group recently earned a three-year grant from the Aligning Science Across Parkinson’s initiative, an international collaborative research effort partnering with The Michael J. Fox Foundation for Parkinson’s Research to implement its funding.